Maria Rosadel Dionisio

Madel has extensive experience in regulatory affairs, clinical research, drug development and manufacturing. She has supported multiple early-phase clinical trials for new diabetes drugs and devices, including continuous glucose monitoring devices, insulin pumps, and artificial pancreas systems. Ms. Dionisio is also a trained chemist with a strong background in GMP manufacturing of drug substances for clinical research and commercial use. She holds a BS in Chemistry with an emphasis in Clinical Biochemistry from the University of the Philippines, Diliman.